Crude Oil Spill in Barataria Bay
The United States Coast Guard reports roughly 8 square miles of the Lake Grande Ecaille area, including a patch of wetlands, have been affected by the 4,200 gallons of crude oil that has spilled from an abandoned flow line in the Lake Washington oil field in Plaquemines Parish.
On February 22, 2016, it was announced that Fresenius Medical Care reached an agreement to set aside $250 million to settle claims stemming from their GranuFlo and Naturalyte dialysis concentrates.
TESI’s finances, operations questioned
By Richard Burgess
LAFAYETTE — The state Public Service Commission is preparing to dig into the finances of Total Environmental Solutions to determine if the company is spending enough money to maintain the more than 200 small water and sewer systems it operates in Louisiana, many of which have come under fire for cloudy and smelly water.
A federal jury awarded a combined $9 billion in punitive damages against Takeda Pharmaceuticals U.S.A. Inc. and Eli Lilly & Co. after it found that the drug makers did not disclose cancer risks for their diabetes medicine, Actos.
The jury in Lafayette, La., awarded the plaintiff $6 billion in punitive damages from Takeda, the U.S. arm of Japan’s largest pharmaceutical firm, and $3 billion from Eli Lilly. The jury also gave the plaintiff compensatory damages of nearly $1.5 million.
The first trial in the multidistrict litigation (MDL) established for all Zoloft birth defect lawsuits filed in federal courts is set to go before a jury in November 2014.
At this time more than 420 personal injury lawsuits against Pfizer have been consolidated in the Eastern District of Pennsylvania before U.S. District Judge Cynthia M. Rufe. All of the lawsuits were filed on behalf of families with children born with serious congenital birth defects allegedly caused by the popular antidepressant. The suits are based on claims that Pfizer failed to provide adequate warnings about the risks linked to Zoloft.
Twenty-five of the cases were selected by Pfizer and the plaintiffs’ lawyers appointed as leadership counsel in the MDL as part of an “Initial Discovery Pool” and are in the process of pretrial discovery.
Johnson & Johnson and lawyers for patients injured by a flawed hip implant announced a multibillion-dollar deal on Tuesday to settle thousands of lawsuits, but it was not clear whether the deal would satisfy enough claimants.
Under the agreement, the medical products giant would pay nearly $2.5 billion in compensation to an estimated 8,000 patients who have been forced to have the all-metal artificial hip removed and replaced with another device. Continue reading
BP wants the world to think the company is a victim, that greedy people are taking advantage of its promise to “make things right” after its broken well spewed millions of barrels of oil into the Gulf of Mexico in 2010.
The company’s PR machine has been in overdrive in recent months trying to sell that message. Nevermind that BP and its lawyers negotiated a court settlement setting up the process for handling damage claims and agreed to the terms, the oil giant is trying to change that process after the fact.
Just 10 days after a federal judge in New Orleans lambasted BP for demanding that businesses must prove their losses were caused by the Deepwater Horizon oil spill before being paid under the terms of a private settlement, an appeals court ordered the judge not to allow such payments without proof that losses resulted from the spill.
Pardon us for peeking inside your medicine cabinet, but are you taking the hot-flash drug Estratest? Using Hylira, a prescription-only dry-skin gel? Or dosing your kids with Carbofed DM syrup for their sniffles? You should know that these products—and thousands more—have never been approved by the U.S. Food and Drug Administration. Yet doctors write an estimated 70 million prescriptions for such drugs each year; they’re sold in pharmacies, and they’re even covered by health insurance.